Journal of Neurovirology

Papers
(The TQCC of Journal of Neurovirology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Possible role of CNS microRNAs in Human Mpox virus encephalitis—a mini-review54
Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report23
Combined effects of older age and HIV disease on changes in everyday functioning over one year22
HIV associated motor neuron disease (MND): A case series with systematic review of literature16
Longitudinal, virological, and serological assessment of hospitalized COVID-19 patients16
Zika virus infection of retinal cells and the developing mouse eye induces host responses that contrasts to the brain and dengue virus infection16
Serum mir-142-3p release in children with viral encephalitis and its relationship with nerve injury and inflammatory response16
Cognitive function and impact on driving after SARS-COV-2 infection in a man with long-standing HIV infection: a case report15
Progressive multifocal leukoencephalopathy in sarcoidosis successfully treated with pembrolizumab15
Sex-specific mitochondrial DNA changes in neuron-derived extracellular vesicles of African American adults: impact of HIV infection and smoking15
Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma14
Serum of COVID-19 patients changes neuroinflammation and mitochondrial homeostasis markers in hippocampus of aged rats14
SARS-CoV-2–associated Guillain–Barre syndrome requires extensive pre- and post-mortem examinations14
Varicella-zoster virus meningitis coincident with bacteremia caused by liver abscess: a case report14
Time since HIV diagnosis is linked to amnestic mild cognitive impairment (MCI) in older adults with HIV13
A case of progressive multifocal leukoencephalopathy with hypogammaglobulinemia and a TCF3 mutation13
HIV-1 and methamphetamine alter galectins -1, -3, and -9 in human monocyte-derived macrophages13
SARS-CoV-2-associated haemorrhagic encephalitis mimicking Herpes encephalitis12
Long-term survival from progressive multifocal leukoencephalopathy in living-donor liver transplant recipient with preformed donor-specific antibody11
Cerebrospinal Fluid Biomarkers of Symptomatic Neurosyphilis in People With HIV Compared with Uninfected Individuals11
Effect of coinfections on neurocognitive functioning among people with clade C HIV infection in Zambia11
Neurological manifestations of COVID-19 in pregnancy: a cross-sectional study11
Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood–brain barrier, beta amyloid, and tau proteins in people living with HIV10
Upregulation of microRNAs correlates with downregulation of HERV-K expression in Parkinson’s disease10
Components of metabolic syndrome associated with lower neurocognitive performance in youth with perinatally acquired HIV and youth who are HIV-exposed uninfected9
Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice9
Herpes simplex encephalitis in patients receiving chemotherapy and whole-brain radiation therapy9
Genetic polymorphisms in innate immunity genes influence predisposition to tick-borne encephalitis9
A human-derived 3D brain organoid model to study JC virus infection9
Detection of human herpesviruses in cerebrospinal fluids collected from patients suspected of neuroinfectious diseases9
Incidence of tick-borne encephalitis (TBE) in the pediatric population at the University Hospitals of Strasbourg (HUS) and characterization of confirmed cases9
HIV-1 Tat drives the Fabp4/NF-κB feedback loop in microglia to mediate inflammatory response and neuronal apoptosis9
Progressive multifocal leukoencephalopathy and peripheral neuropathy in a patient with Good’s syndrome9
Herpesviruses, polyomaviruses, parvoviruses, papillomaviruses, and anelloviruses in vestibular schwannoma8
Simian varicella virus infection and reactivation in rhesus macaques trigger cytokine and Aβ40/42 alterations in serum and cerebrospinal fluid8
Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study8
Designing a cellular MicroRNA-based approach to silence bat-borne Nipah virus genes7
HIV-associated multiple intracranial aneurysms and stroke in an adult patient: successful treatment with a combination of glucocorticoid and antiviral agents7
Correction to: Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system7
A case of ischemic stroke secondary to varicella-zoster virus meningoencephalitis7
Influence of plasma exosomes from women living with HIV Stratified by HAND on monocyte subpopulations from healthy women without HIV7
Increased expression of PD-1 in CD8 + CD3 + T cells correlates with EBV viral load in MS patients7
Differential effects of fentanyl compared to morphine on neuroinflammatory signaling in the brain in EcoHIV-infected mice7
Evolving etiologies, comorbidities, survival, and costs of care in adult encephalitis7
Infection of human microglial cell line CHME-3 to study neuropathogenesis of chikungunya virus6
Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers6
Comment on “Limited HIV-associated neuropathologies and lack of immune activation in sub-saharan African individuals with late-stage subtype C HIV-1 infection”6
A rare kind of Guillain-Barre syndrome triggered by acute hepatitis A infection in a pediatric patient: a case report and review of literature6
In vitro characterization of the antiviral activity of Bat Interferon-Induced protein with tetratricopeptide repeats 5 (bat IFIT5) against bat-associated rabies virus6
Expression in skin biopsies supports genetic evidence linking CAMKK2, P2X7R and P2X4R with HIV-associated sensory neuropathy6
Cerebral and spinal cord changes observed through magnetic resonance imaging in patients with HTLV-1–associated myelopathy/tropical spastic paraparesis: a systematic review6
Cognitive deficits in HTLV-1 patients6
A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system5
Implications of vascular depression for successful cognitive aging in HIV Disease5
Characterizing Epstein-Barr virus infection of the central nervous system in Zambian adults living with HIV5
Metformin promotes PEN2 expression to attenuate microglia-mediated neurotoxicity induced by HIV-1 Tat5
A pilot study of cognition and creativity among persons with HIV disease referred for neuropsychological evaluation5
Limited evidence for a moderating effect of HIV status on brain age in heavy episodic drinkers5
Catastrophic tumefactive acute disseminated encephalomyelitis in patient with dengue virus: a case report5
Cytomegalovirus infection induces Alzheimer’s disease-associated alterations in tau5
Evaluation of the effects of the Zika Virus-Immunoglobulin G+ complex on murine microglial cells5
Generating fair, reliable, and accurate neuropsychological test norms for people with HIV in a low- or middle-income country5
Detection of human neurotropic JCPyV DNA sequence in pediatric anaplastic xanthoastrocytoma5
Innate immune memory in chronic HIV and HIV-associated neurocognitive disorders (HAND): potential mechanisms and clinical implications5
Maintaining the battle against vaccine-preventable neurological diseases in the United States5
Rapid-progressing progressive multifocal leukoencephalopathy in two patients newly diagnosed with HIV: case series and review of literature5
Myelin regulatory factor is a target of individual and interactive effects of HIV-1 Tat and morphine in the striatum and pre-frontal cortex4
The incidence of symptomatic CSF viral escape in patients on antiretroviral therapy in western India: a retrospective cohort study4
HSV-1 latency-associated transcript miR-H3 and miR-H4 target STXBP1 and GABBR2 genes4
Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid4
Neuroimaging and immunological features of neurocognitive function related to substance use in people with HIV4
Cortico-striatal networking deficits associated with advanced HIV disease and cocaine use4
Differential expression of cellular prion protein (PrPC) in mouse hepatitis virus induced neuroinflammation4
Stroke risk after varicella-zoster virus infection: a systematic review and meta-analysis4
T-lymphocyte activation markers in patients with HIV-1-associated neurocognitive disorder4
Monkeypox virus replication underlying circadian rhythm networks4
Cooperative interactions between neurotrophin receptors and CXCR4 regulate macrophage phenotype and susceptibility to activation by HIV4
The relationship between vascular endothelial growth factor (VEGF) and amnestic mild cognitive impairment among older adults living with HIV4
Cerebral vasculitis caused by Talaromyces marneffei and Aspergillus niger in a HIV-positive patient: a case report and literature review4
Response to “a fatal case of Guillain-Barré syndrome after infection with COVID-19”4
Encephalomyelitis in a patient with monkeypox: an unusual complication4
Mapping ACE2 and TMPRSS2 co-expression in human brain tissue: implications for SARS-CoV-2 neurological manifestations4
Systematic post-mortem analysis of brain tissue from an HIV-1 subtype C viremic decedent revealed a paucity of infection and pathology4
0.86259889602661